Answers are grounded in this paper and cite their sources.
In patients with first episode Clostridium difficile infection treated with vancomycin or fidaxomicin, more patients receiving fidaxomicin achieved at least 2 log10 colony-forming units/g reduction in spores at the follow-up visit (P=.02). Similar to published literature, a higher proportion of patients receiving fidaxomicin demonstrated sustained clinical response.
No takes yet. Share an insight, caveat, or question.
Housman et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: